Loading...

Innoviva, Inc.

INVANASDAQ
Healthcare
Biotechnology
$18.25
$-0.21(-1.14%)

Innoviva, Inc. (INVA) Stock Overview

Explore Innoviva, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.6/100

Key Financials

Market Cap1.2B
P/E Ratio29.80
EPS (TTM)$0.57
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$22.70
1 Month$21.78
3 Months$20.82
1 Year Target$23.57

INVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Innoviva, Inc. (INVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $23.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.80 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;